LATEST ALERTS
Companies are trying new ways to reach cannabinoid customers in severely restricted Australia, but they must be careful not to fall foul of strict guidelines that separate promoting from simply informing the public about prescription goods
Hemp grown from EU-certified seeds or of less than 0.2% THC is exempt from the legal definition of cannabis in Estonia. This report offers a detailed overview of the legal regime for CBD, hemp and cannabis in Estonia
A hold has been placed on European novel food assessment after the European Food Safety Authority (EFSA) said it was unable to proceed due to identified knowledge gaps in safety data
The Peruvian Health Ministry has published a draft legal framework that will regulate the medicinal and therapeutic cannabis market following the 16th May resolution promising such a move
Spending on CBD- and cannabis-related lobbying in the US exceeded pre-pandemic numbers, with more than $12m spent during the first quarter of 2022 on issues such as efforts to support patient safety, legalisation and decriminalisation
The North Carolina senate has passed a law confirming the legality of hemp before the state’s pilot programme finishes at the end of June. It now moves to the House
The US Food and Drug Administration (FDA) has issued warnings to four companies that have sold veterinary products containing CBD
The US is in danger of being left behind the burgeoning global cannabis market because of a lack of political will to commit to any form of federal cannabis reform
This report offers a detailed overview of Switzerland’s regulatory regime for cannabis, CBD and hemp, covering all policy areas and discussing future changes to the law
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Get 7 days of access to industry updates through our news analysis and regulatory alerts
"*" indicates required fields
